The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

Health-care professionals, eager to support their patients diagnosed with diabetes or obesity, are writing more prescriptions ...

Despite substantial health benefits, two GLP-1 receptor agonists weren't cost-effective at their current prices, according to ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Many Marylanders struggle with obesity but cannot get access to weight loss medications because insurance will not pay for ...

The administration is reviewing a Centers for Medicare and Medicaid Services rule that would expand coverage to Medicare and Medicaid recipients ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

One effective action involves addressing obesity, a major driver of chronic disease and health care costs. Obesity is an ...

India must note that obesity is a public health challenge, waiting for holistic, multipronged and comprehensive interventions ...

The Canadian Medical Association and the World Health Organization (WHO) consider obesity as a progressive chronic disease ...

Obesity is a chronic, progressive disease that affects one-third of adults in Florida. We cannot afford to continue ignoring ...